(CTN News) – Despite slumping sales of the Covid vaccine, the company’s only marketable product, Moderna posted a surprise quarterly profit on Thursday. With the world emerging from pandemics and utilising fewer protective shots and treatments, the biotech company and other Covid vaccine makers have had a rocky year. According to LSEG, formerly known as […]

Go to Source
Author: Salman Ahmad